^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TT-816

    i
    Other names: TT-816
    Associations
    News
    Trials
    Company:
    Teon Therap
    Drug class:
    Cannabinoid receptor 2 antagonist
    Associations
    News
    Trials